A synthetic heparin oligosaccharide decouples anticoagulation from heparin-induced thrombocytopenia risk
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
This study used chemoenzymatic synthesis to engineer homogeneous dodecasaccharide 12G-2, decoupling anticoagulant efficacy from HIT risk via dual structural modulation.
Appeared: Friday, November 6. Science Translational Medicine. Peer-reviewed journal.